This content is produced and promoted by Amgen

Patient Resources


Refer to full Product Information for Prolia (denosumab) and Evenity (romosozumab) before prescribing; available from Amgen Australia Pty Ltd, Ph: 1800 803 638 or for Prolia (denosumab) by clicking here and Evenity (romosozumab) here.


Amgen is committed to supporting your practice and osteoporosis patients. Find out more about treatment with Prolia or Evenity (romosozumab) and what support is available.


Prolia PI Click Here
Prolia CMI Click Here
Prolia Prolong Support System Download


Evenity PI Click Here
Evenity CMI Click Here
Evenity Support Program Download






Don't wait for a break, screening is essential.

Let’s be clear:
Top osteoporosis myths busted

How is Amgen supporting you and your patients?


PBS information: Authority required (STREAMLINED) as treatment for osteoporosis. Criteria Apply. Refer to PBS Schedule for full Authority Required information.

Refer to full Product Information before prescribing; available from Amgen Australia Pty Ltd, Ph: 1800 803 638 or at

For more information on Prolia® or to report an adverse event or product complaint involving Prolia®, please contact Amgen Medical Information on 1800 803 638 or visit


References: 1. Watts JJ, et al. Osteoporosis costing all Australians - A new burden of disease analysis 2012 to 2022. Osteoporosis Australia, 2013. 2. Amgen Australia, Data on File, 2020 (patients not treated).  3. Australian Bureau of Statistics. Estimated Resident Population, 2018. Available at[email protected]/DetailsPage/3101.0Jun%202018?OpenDocument. Accessed 30 January 2020.  4. Henry MJ, et al. Med J Aust 2011; 195: 321–22. 5. Australian Bureau of Statistics. 2017-18 National Health Survey. Available at[email protected]/mf/4364.0.55.001. Accessed 30 January 2020.  6. Medicare Australia dataset up to Oct 2020 extrapolated (2020/MI8392), received 12/20.  7. Healthy Bones Australia. Bone density testing in general practice. Available at: [Accessed: January 2022] 8. Royal Australian College of General Practitioners. Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. East Melbourne, Vic: RACGP, 2017.

Amgen logo

Amgen Australia Pty Ltd, Sydney NSW 2000. ABN 31 051 057 428. Medical Information: 1800 803 638. Phone: +61 2 9870 1333. Approved: March 2022. AMG3876. AU-16811.